Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Pancreatic Inflammation & Potential Pancreatic Damage While GLP-1 receptor agonists (e.g., Ozempic, Wegovy, Mounjaro) are widely used and carry established warnings for acute pancreatitis, extensive large-scale studies show the overall absolute risk remains very low, and long-term data indicates they do not increase the lifetime risk of pancreatic damage for most patients Pancreatitis is a known risk of GLP-1 drugs, but long-term consequences are still being studied
For instance, increased PPP flux has been observed in cancer cells, providing metabolic advantages for their rapid proliferation and survival
Prior pancreatitis, gallbladder disease, kidney problems, diabetic retinopathy, significant gastrointestinal symptoms, and use of insulin or sulfonylureas may require closer risk assessment rather than automatic exclusion
Dosing and administration The standard clinical protocol calls for 2mg administered subcutaneously once daily, typically in the abdominal region with injection sites rotated regularly
95% CI 2.08 to 2.61
That does not mean intranasal delivery is impossible or unexplored
US$ 20.46
US$ 29.54
US$ 25.92
US$ 20.28
US$ 24.06
